IOglime-ER
Type:
Tablet
Pack:
10x10
Packing:
Alu Alu
Category:
DIABETOLOGY
Price:
₹1,350.00
Contact Us to Purchase
Composition Details
Glimepiride 2mg + Metformin 500mg + Pioglitazone 15mg
Description & Effects
IOglime-ER is a combination medication containing Glimepiride (2 mg), Metformin (500 mg), and Pioglitazone (15 mg), used primarily in the management of type 2 diabetes. Each component works through a unique mechanism to help control blood sugar levels, addressing different aspects of the condition for more comprehensive management.Glimepiride is a sulfonylurea that stimulates the pancreas to release more insulin, which helps lower blood glucose levels. By increasing insulin secretion, it works to counteract the body’s resistance to insulin, making glucose metabolism more efficient.
Metformin is a biguanide that works by reducing the amount of glucose produced by the liver and improving the body's sensitivity to insulin. It also helps decrease the absorption of glucose from the intestines, leading to better control of blood sugar levels after meals.
Pioglitazone is a thiazolidinedione that works by increasing the body's sensitivity to insulin, helping cells take up glucose more effectively. It reduces insulin resistance in muscle, liver, and fat cells, leading to better glucose utilization.
The extended-release (ER) formulation of IOglime-ER allows for a slower release of the active ingredients, helping to maintain more stable blood glucose levels over time and reducing the frequency of side effects typically seen with immediate-release versions of these medications.
Together, this combination helps control hyperglycemia by working through multiple pathways to regulate insulin production, improve insulin sensitivity, and reduce excess glucose production, making it a powerful tool in the management of type 2 diabetes. It is typically prescribed when lifestyle changes and single-agent therapies are not sufficient to control blood sugar.
